Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04734041
Other study ID # DH10320
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 23, 2020
Est. completion date July 2, 2021

Study information

Verified date July 2021
Source National University of Natural Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)


Description:

The overall purpose of this study is to assess the feasibility of conducting a 9-week integrative medicine program that is comprised of a prescribed anti-inflammatory (Mediterranean) diet, as well as general behavioral and psychosocial support among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS), in order to determine the recruitment potential in this population and to measure the ability of individuals to complete the program. Participants will be prescribed a food plan, and adherence to and feasibility of the food plan will be measured through participant food tracking and a subjective assessment of the food plan in a brief satisfaction survey. This study aims to recruit 20 patients with HSD or EDS and make preliminary observations regarding the effects of integrative medical care on pain reduction and improved quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date July 2, 2021
Est. primary completion date July 2, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age 18-65 - Beighton score of 4 or more to confirm joint hypermobility diagnosis - Baseline VAS Score of 1 or more - Not currently, or already a patient of Dr. Schaefer and Healthy Living Community - Ability to provide written informed consent - Willingness to participate in 9-week integrative medicine intervention (and make dietary and lifestyle changes) - Willingness to attend 1 in-person screening visit and 2 virtual office visits (or 3 virtual visits, if medical documentation of Beighton score can be provided in advance of enrollment, and all other criteria are met) - Access to an electronic device for MyFitnessPal food-tracker use (i.e mobile device, tablet, laptop) Exclusion Criteria: - Pregnant and lactating women, or planned pregnancy over the next 3 months - Consumption of more than 14 (men) or 7 (women) alcoholic drinks per week - History of disordered eating or eating disorder - Body mass index (BMI) considered underweight (<18.5) - Weight loss from metastatic cancer - Unable to make dietary changes or participate in a 9-integrative medicine nutritional intervention - Those with significant dietary changes, new medications, or new exercise routines within the past 90 days - Currently, or already, a patient of Dr. Schaefer and Healthy Living Community

Study Design


Intervention

Behavioral:
Anti-inflammatory (Mediterranean-style) diet
Prescription of an anti-inflammatory diet, which encourages increasing whole fruits, vegetables, and grains, as well as balancing macronutrients (proteins, carbohydrates, and fat) for every meal.
Behavioral and psychosocial support
Capture a complete and detailed medical history and background. Discuss familial and social support, provide psychosocial support, assess the patient's current self-management strategies for self-care, and assess the patient's current self-management strategies for mental health. Recommendations will be made in accordance with the needs of the participant.

Locations

Country Name City State
United States Healthy Living Community Portland Oregon
United States National University of Natural Medicine Portland Oregon

Sponsors (2)

Lead Sponsor Collaborator
National University of Natural Medicine Healthy Living Community

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Visual Analog Scale for Pain (VAS) Baseline, 5-week, and 9-week pain scale scores on a 10-point scale. The numeric measurement of pain between 0 "no pain" and 10 representing "worst pain" will be used. Baseline, 5 weeks, 9 weeks
Other Patient-Reported Outcomes Measurement Information System (PROMIS-29) Baseline, 5-week, and 9-week PROMIS pain intensity on a scale of 0 to 10. Higher scores represent greater intensity of pain. Baseline, 5 weeks, 9 weeks
Other Patient Assessment of Chronic Illness Care (PACIC+) Baseline, 5-week, and 9-week assessment. The PACIC+ consists of 26 items with Likert scale responses on a 5 point scale from "Almost never" to "Almost always," with higher scores representing greater satisfaction with care. The PACIC provides summary scores for attitudes regarding patient-centered care, living with chronic illness, and chronic illness care. All subscales are averages of selected items that range between 1 (poor quality of care received) and 5 (excellent quality of care received). Baseline, 5 weeks, 9 weeks
Primary Recruitment rate Number of participants enrolled per month, over the 4 month open recruitment 9 weeks
Primary Retention rate Proportion of participants completing the mid-study or end-of-study visits 9 weeks
Secondary Adherence to the dietary recommendations Estimated daily dietary intake recorded in a food tracker app 5, 9 weeks
Secondary Adherence to food tracking Reporting per week of dietary intake recorded in a food tracker app 5, 9 weeks
See also
  Status Clinical Trial Phase
Completed NCT04437589 - Opioid-Free Anesthesia for Patients With Joint Hypermobility Syndrome Undergoing Craneo-Cervical Fixation: A Case-series
Completed NCT04680793 - Effects of a Multidisciplinary Outpatient Rehabilitation Program in Patients With Ehlers-Danlos Syndrome. N/A
Not yet recruiting NCT05279937 - The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients Phase 3
Enrolling by invitation NCT05429996 - Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
Not yet recruiting NCT03575182 - Gait Retraining in Patients With Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome N/A
Recruiting NCT05561270 - Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome N/A
Completed NCT01322165 - National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions N/A
Active, not recruiting NCT05603741 - Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers Phase 4
Enrolling by invitation NCT05434728 - Characterization of Bleeding Disorders in EDS
Completed NCT01356134 - Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI) N/A
Completed NCT05137379 - Evaluation of a Cohort of Patients With Ehlers-Danlos Syndrome Treated With Orthopedic Surgery (SED-eval)
Recruiting NCT02050113 - Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices N/A
Recruiting NCT04890431 - Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome Phase 4
Completed NCT03602482 - Standing Cognition and Co-morbidities of POTS Evaluation N/A
Recruiting NCT04133272 - Registry of Ehlers-Danlos Syndrome
Completed NCT05516043 - Safety and Performance of POLYTHESE® Vascular Prosthesis
Recruiting NCT06105541 - Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation N/A
Enrolling by invitation NCT04036305 - Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
Recruiting NCT03596437 - Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome N/A
Completed NCT00270686 - Studies of Heritable Disorders of Connective Tissue